← Leaderboards
Donald P Waller
Mount Sinai School Of Medicine Of Nyu
$987,837
Attributed
$3,951,347
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $999.1K · FY2017–20$1M$750K$500K$250K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$3,951,347 · 2
By mechanism
R44$3,951,347 · 1
P01$0 · 1
Top collaborators
- Barbara Best North4 shared
- Mary B Weitzel4 shared
- Ann E. Jerse2 shared
- Michael J Oldham2 shared
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Marla J Keller$31,813,832
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroPharmaceutical PreparationsFundingHyaluronanMedicalNovel TherapeuticsEfficacy StudyFormulationFutureGuidelinesCyclic GmpDesignNeisseria GonorrhoeaeDoseClinical TrialsContraceptive EfficacyFeedbackCharacteristicsAnalytical MethodContraceptive AgentsBaseGrantBindingPharmacologic Substance
Grant awards (6)
Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND$984,778
R44 · FY2020 · HD
Continuing Preclinical Development of PPCM Vaginal Contraceptive MPT to IND$999,102
R44 · FY2019 · HD
Preclinical development of PPCM vaginal contraceptive to submit IND.$982,217
R44 · FY2018 · HD
Preclinical development of PPCM vaginal contraceptive to submit IND.$985,250
R44 · FY2017 · HD
Core--chemistry facility$0
P01 · FY2002 · HD
Core--chemistry facility$0
P01 · FY2001 · HD